Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenyang Pharma Univ. HIF-1α/EZH2 compound D-01
- Development stage
- Preclinical
- Lead developer
- Shenyang Pharmaceutical University
01
Overview
Shenyang Pharma Univ. HIF-1α/EZH2 compound D-01: sourced facts only. name: "Among these compounds, D-01 had significant inhibitory activities on HIF-1α and EZH2."; target: "Among these compounds, D-01 had significant inhibitory activities on HIF-1α and EZH2."; target: "Among these compounds, D-01 had significant inhibitory activities on HIF-1α and EZH2."; developer: "Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China."; stage: "In vitro experiments showed that D-01 significantly inhibited the migration of A549 cells, clone, invasion and angiogenesis."
02
Targets
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Go deeper on Shenyang Pharma Univ. HIF-1α/EZH2 compound D-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenyang Pharma Univ. HIF-1α/EZH2 compound D-01.
Work on Shenyang Pharma Univ. HIF-1α/EZH2 compound D-01? Claim this page to correct or add information. Claim this page